Location: San Diego, CA
CIK: 0001232621 · Show all filings
Period: Q1 2026 (← Previous) (Next →)
Filing Date: May 15, 2026
Total Value: $1.969B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Share Price | Est. Cost/Share | Unrealized @ Report Date | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|---|
| AUPH | AURINIA PHARMACEUTICALS INC | 12,229,500 | $181M | 9.2% | $14.82 | $7.96 | +85.8% | COM | 05156V102 |
| CELC | CELCUITY INC | 1,050,000 | $120M | 6.1% | $114.14 * | $40.03 | +168.5% | COM | 15102K100 |
| MIRM | MIRUM PHARMACEUTICALS INC | 1,236,027 | $114M | 5.8% | $92.38 * | $22.11 | +336.8% | COM | 604749101 |
| GLPG | GALAPAGOS NV | 3,785,991 | $114M | 5.8% | $30.00 | $26.90 | — | SPON ADR | 36315X101 |
| SPY | STATE STR SPDR S&P 500 ETF T | 168,000 | $109M | 5.5% | $650.34 | $655.98 | — | TR UNIT | 78462F103 |
| KNSA | KINIKSA PHARMACEUTICALS INTL | 2,259,889 | $109M | 5.5% | $48.15 * | $20.52 | +110.4% | ORD SHS CL A | G52694109 |
| CAPR | CAPRICOR THERAPEUTICS INC | 3,399,900 | $103M | 5.2% | $30.40 * | $18.97 | +31.2% | COM NEW | 14070B309 |
| PTCT | PTC THERAPEUTICS INC | 1,500,000 | $102M | 5.2% | $68.13 * | $37.71 | +95.4% | COM | 69366J200 |
| SYRE | SPYRE THERAPEUTICS INC | 1,892,200 | $95.44M | 4.8% | $50.44 * | $18.65 | +85.2% | COM NEW | 00773J202 |
| KALV | KALVISTA PHARMACEUTICALS INC | 4,573,530 | $92.07M | 4.7% | $20.13 * | $10.28 | +50.6% | COM | 483497103 |
| CMPX | COMPASS THERAPEUTICS INC | 16,790,809 | $88.82M | 4.5% | $5.29 * | $2.28 | +163.7% | COM | 20454B104 |
| TARS | TARSUS PHARMACEUTICALS INC | 1,188,624 | $83.38M | 4.2% | $70.15 | $18.91 | +268.6% | COM | 87650L103 |
| IMCR | IMMUNOCORE HLDGS PLC | 2,649,368 | $79.88M | 4.1% | $30.15 | $31.44 | — | ADS | 45258D105 |
| ANAB | ANAPTYSBIO INC | 1,330,879 | $73.81M | 3.7% | $55.46 * | $20.84 | +136.9% | COM | 032724106 |
| CORT | CORCEPT THERAPEUTICS INC | 1,500,000 | $60.47M | 3.1% | $40.31 * | $42.95 | -9.7% | COM | 218352102 |
| ANIP | ANI PHARMACEUTICALS INC | 707,500 | $54.41M | 2.8% | $76.90 * | $74.20 | +8.3% | COM | 00182C103 |
| INSM | INSMED INC | 260,000 | $42.52M | 2.2% | $163.52 * | $135.63 | +17.3% | COM PAR $.01 | 457669307 |
| BNTX | BIONTECH SE | 470,000 | $41.77M | 2.1% | $88.88 | $108.74 | — | SPONSORED ADS | 09075V102 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 1,792,626 | $35.06M | 1.8% | $19.56 * | $16.12 | +91.3% | COM | 92790C104 |
| AVIR | ATEA PHARMACEUTICALS INC | 4,814,700 | $25.9M | 1.3% | $5.38 * | $3.66 | +8.7% | COM | 04683R106 |
| PGEN | PRECIGEN INC | 6,417,500 | $24.84M | 1.3% | $3.87 * | $3.03 | +48.3% | COM | 74017N105 |
| DNTH | DIANTHUS THERAPEUTICS INC | 264,692 | $22.21M | 1.1% | $83.92 * | $12.62 | +277.1% | COM | 252828108 |
| CMPS | COMPASS PATHWAYS PLC | 4,002,200 | $22.13M | 1.1% | $5.53 | $5.53 | — | SPONSORED ADS | 20451W101 |
| CBIO | CRESCENT BIOPHARMA INC. | 1,160,000 | $21.31M | 1.1% | $18.37 * | $12.97 | -14.8% | COM | G2545C104 |
| STOK | STOKE THERAPEUTICS INC | 500,000 | $16.28M | 0.8% | $32.56 * | $11.10 | +186.8% | COM | 86150R107 |
| VKTX | VIKING THERAPEUTICS INC | 500,000 | $16.27M | 0.8% | $32.54 * | $36.82 | -14.9% | COM | 92686J106 |
| IDYA | IDEAYA BIOSCIENCES INC | 450,000 | $14.99M | 0.8% | $33.32 | $25.04 | +35.2% | COM | 45166A102 |
| NUVB | NUVATION BIO INC | 3,149,557 | $13.51M | 0.7% | $4.29 * | $1.54 | +300.7% | COM CL A | 67080N101 |
| PLRX | PLIANT THERAPEUTICS INC | 6,143,132 | $7.74M | 0.4% | $1.26 | $5.97 | -79.2% | COM | 729139105 |
| DERM | JOURNEY MED CORP | 1,610,000 | $7.551M | 0.4% | $4.69 * | $5.43 | +51.2% | COM | 48115J109 |
| JANX | JANUX THERAPEUTICS INC | 500,000 | $6.95M | 0.4% | $13.90 | $13.66 | 0.0% | COM | 47103J105 |
| BIIB | BIOGEN INC | 35,000 | $6.417M | 0.3% | $183.33 | $217.32 | -15.7% | COM | 09062X103 |
| URGN | UROGEN PHARMA LTD | 350,000 | $6.293M | 0.3% | $17.98 * | $9.60 | +117.2% | COM | M96088105 |
| ARVN | ARVINAS INC | 538,658 | $5.71M | 0.3% | $10.60 * | $15.67 | -19.8% | COM | 04335A105 |
| PMVP | PMV PHARMACEUTICALS INC | 4,245,085 | $5.264M | 0.3% | $1.24 * | $1.38 | -18.7% | COM | 69353Y103 |
| MRNA | MODERNA INC | 100,000 | $5.08M | 0.3% | $50.80 * | $36.16 | +18.7% | COM | 60770K107 |
| HRTX | HERON THERAPEUTICS INC | 6,250,000 | $5.001M | 0.3% | $0.80 * | $2.22 | -41.1% | COM | 427746102 |
| KZR | KEZAR LIFE SCIENCES INC | 664,314 | $4.929M | 0.3% | $7.42 * | $7.45 | -15.4% | COM NEW | 49372L209 |
| WVE | WAVE LIFE SCIENCES LTD | 600,000 | $4.35M | 0.2% | $7.25 * | $10.16 | +35.3% | SHS | Y95308105 |
| LENZ | LENZ THERAPEUTICS INC | 451,114 | $4.128M | 0.2% | $9.15 * | $21.01 | -25.2% | COM | 52635N103 |
| AGIO | AGIOS PHARMACEUTICALS INC | 100,000 | $3.383M | 0.2% | $33.83 * | $28.04 | 0.0% | COM | 00847X104 |
| ERAS | ERASCA INC | 200,000 | $3.236M | 0.2% | $16.18 * | $1.85 | +441.7% | COM | 29479A108 |
| CHRS | COHERUS ONCOLOGY INC | 1,886,748 | $3.189M | 0.2% | $1.69 * | $1.38 | +32.3% | COM | 19249H103 |
| NKTX | NKARTA INC | 1,480,823 | $3.125M | 0.2% | $2.11 * | $3.05 | -28.5% | COM | 65487U108 |
| ALT | ALTIMMUNE INC | 666,022 | $2.051M | 0.1% | $3.08 * | $9.59 | -51.4% | COM NEW | 02155H200 |
| EOLS | EVOLUS INC | 483,021 | $1.985M | 0.1% | $4.11 * | $10.07 | -51.4% | COM | 30052C107 |
| ABEO | ABEONA THERAPEUTICS INC | 400,000 | $1.792M | 0.1% | $4.48 * | $5.03 | +2.6% | COM NEW | 00289Y206 |
| FATE | FATE THERAPEUTICS INC | 1,167,773 | $1.401M | 0.1% | $1.20 | $3.85 | -68.7% | COM | 31189P102 |
| NMRA | NEUMORA THERAPEUTICS INC. | 439,878 | $858K | 0.0% | $1.95 * | $1.71 | +43.8% | COM | 640979100 |
| LXRX | LEXICON PHARMACEUTICALS INC | 399,700 | $624K | 0.0% | $1.56 * | $1.35 | 0.0% | COM NEW | 528872302 |
| RCKT | ROCKET PHARMACEUTICALS INC | 100,000 | $358K | 0.0% | $3.58 | $23.10 | -84.4% | COM | 77313F106 |